Mothers-to-be should weigh risks of antidepressants during pregnancy

April 23rd, 2009 by Jennifer Walker-Journey

depression 150x150 Mothers to be should weigh risks of antidepressants during pregnancyYears ago, it was thought that protected women from depression, but researchers have since learned that being pregnant and recent childbirth may actually contribute to a woman’s depression, filling her with a range of emotions that make dealing with the symptoms of the condition even more difficult. According to the Mayo Clinic, an estimated 10 percent of women experience depression during .

Seeking help from a health care provider is vital not only to the mother, but to her unborn child. Depressed mothers-to-be may not have the energy to take care of themselves or seek optimal prenatal care. She may even rely on smoking cigarettes or drinking alcohol to cope, which can have detrimental effects on an unborn child. Health care providers can discuss healthier options, such as group or one-on-one therapy. In some cases, may be recommended.

According to the Mayo Clinic, few medications have been proven safe beyond a doubt for use during , which is why many doctors advise their patients who are pregnant or are considering to wean off most drugs. However, some , such as selective serotonin reuptake inhibitors (SSRIs), should only be taken during after a woman weighs the risks with her doctor because of the possibility of serious birth defects.

Common SSRIs that have previously been prescribed for depression during include Celexa, Prozac, Zoloft and Paxil. However, with all those medications there is a possible risk of persistent pulmonary hypertension, or PPHN, in the newborn. The risk is so rare that Celexa, Prozac and Zoloft are still considered options for use during .

However, in 2005, a scientific study indicated that women who took during the first three months of had a greater risk of their unborn child developing – in particular – than any other antidepressant. As a result of that study, GlaxoSmithKline, makers of , updated the PRECAUTIONS section of its medication label discouraging use of during .

The Mayo Clinic urges women to consult with their doctors and learn the risks and benefits of during before making a decision.

blog comments powered by Disqus

Comments are moderated and generally will be posted if they are on-topic and not abusive.